Travel support request for US participants in BIOT-ESBES meeting (Istanbul, Turkey) from September 23-26, 2012

为 2012 年 9 月 23 日至 26 日参加 BIOT-ESBES 会议（土耳其伊斯坦布尔）的美国与会者申请差旅补助

• 批准号: 1246225
• 负责人: William Kelly
• 金额: $ 2万
• 依托单位: Villanova University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-15 至 2013-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1246225&HistoricalAwards=false
• 关键词: Travel; support; request; US; participants

1246225/ KellyThis award from the Biotechnology, Biochemical and Biomass Engineering Program of the National Science Foundation will support the participation of thirteen US scientists and engineers who are participating in the 9th European Symposium(http://events.dechema.de/best2012) on Biochemical Engineering to be held in Istanbul, Turkey from September 23-26, 2012. Bioengineering and the separation of biomolecules are the main focus of this jointly organized event of BIOT, ESBES and ISPPP. The symposium will take place at the same time and at the same place as ECB15, the 15th European Congress on Biotechnology, allowing for the unique opportunity to visit the complete scientific program of all these congresses. The idea of this summit is to bring together the international scientific communities in these fields, to foster communication, cooperation, and cross-disciplinary exchange of ideas in analyzing the impact of the life sciences industry in addressing humanity's great challenges. This event will provide a unique platform for scientists both from industry and academia to discover new science, technologies, processes and applications.The meeting is being organized by a coordination group consisting of eight individuals from ESBES and William J. Kelly (Villanova University, PA/USA) who, as a current member of the ACS BIOT executive board, is representing ACS BIOT. A diverse ACS BIOT subcommittee was created for the purposes of identifying US scientists and engineers to invite as technical presenters and keynote speakers at the ECB15 conference in Istanbul.Intellectual MeritThis conference is a pre-eminent venue in Europe for discussing research at the cutting edge of this diverse and rapidly expanding field. This particular meeting provides a unique opportunity for US scientists from not one but these four different but overlapping technical areas involved, to interact with their European counterparts. The thirteen US participants will be primarily chairing or giving technical presentations in the following areas: Frontiers and innovations in biopharmaceuticals, Nanotechnology in bioprocessing, Stem cell bioengineering and cell therapy and tissue engineering and Systems biotechnology and metabolic engineering. Five of the US speakers were invited to give keynote talks to launch sessions that would be followed by shorter technical talks in the same topical area.Broader ImpactsThe focus of this conference will be on research at the cutting-edge of the field of biotechnology in Europe and the US. The conference organizers have made a significant effort to invite and recruit US speakers and session chairs from groups underrepresented in science and engineering. Dr. Claudia Schmidt-Dannert from the University of Minnesota is one of the five US participants giving a keynote presentation. Furthermore, three of the thirteen US participants are from the US biopharmaceuticals industry and the remaining seven are US academics representing universities spanning the US from west to the east coasts. As a result of this first collaboration between BIOT and ESBES, there is the opportunity for increasing exchange between researchers in the flagship scientific organizations in Europe and the US in the areas of biotechnology. This is a first step in increased interaction between these two important research communities.

1246225/Kelly 这个来自美国国家科学基金会生物技术、生物化学和生物质工程项目的奖项将支持 13 名美国科学家和工程师参加第九届欧洲研讨会 (http://events.dechema.de/best2012)生化工程将于2012年9月23-26日在土耳其伊斯坦布尔举行。生物工程和生物分子分离是主要焦点BIOT、ESBES 和 ISPPP 联合举办的活动。该研讨会将与第 15 届欧洲生物技术大会 ECB15 同期同地举行，为参观所有这些大会的完整科学项目提供了独特的机会。本次峰会的目的是汇集这些领域的国际科学界，促进沟通、合作和跨学科思想交流，分析生命科学行业对应对人类巨大挑战的影响。此次活动将为工业界和学术界的科学家提供一个独特的平台，以发现新的科学、技术、流程和应用。会议由来自 ESBES 和 William J. Kelly（宾夕法尼亚州维拉诺瓦大学）的 8 名人员组成的协调小组组织/USA），作为 ACS BIOT 执行委员会的现任成员，代表 ACS BIOT。一个多元化的 ACS BIOT 小组委员会的成立是为了确定邀请美国科学家和工程师在伊斯坦布尔举行的 ECB15 会议上作为技术演讲者和主旨演讲人。这个多样化且迅速扩展的领域。这次特别的会议为来自四个不同但重叠的技术领域的美国科学家提供了一个与欧洲同行互动的独特机会。十三名美国参与者将主要在以下领域主持或进行技术演讲：生物制药的前沿和创新、生物加工纳米技术、干细胞生物工程和细胞治疗和组织工程以及系统生物技术和代谢工程。五位美国演讲者受邀在启动会议上发表主题演讲，随后将在同一主题领域进行较短的技术演讲。 更广泛的影响本次会议的重点将是欧洲生物技术领域的前沿研究和美国。 会议组织者做出了巨大努力，邀请和招募来自科学和工程领域代表性不足的群体的美国演讲者和会议主席。明尼苏达大学的 Claudia Schmidt-Dannert 博士是发表主题演讲的五位美国与会者之一。此外，13名美国参与者中有3名来自美国生物制药行业，其余7名是代表美国从西海岸到东海岸的大学的美国学者。由于 BIOT 和 ESBES 之间的首次合作，欧洲和美国旗舰科学组织的研究人员之间有机会在生物技术领域加强交流。 这是加强这两个重要研究团体之间互动的第一步。